Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA410067
Max Phase: Preclinical
Molecular Formula: C50H75N9O11
Molecular Weight: 978.20
Molecule Type: Small molecule
Associated Items:
ID: ALA410067
Max Phase: Preclinical
Molecular Formula: C50H75N9O11
Molecular Weight: 978.20
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)N(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)NC(CO)(CO)CO)C(C)C)C(=O)OCc1ccccn1
Standard InChI: InChI=1S/C50H75N9O11/c1-8-33(6)43(48(68)70-26-35-17-12-13-19-52-35)56-44(64)37(32(4)5)24-42(63)38(21-31(2)3)54-46(66)41(23-36-25-51-30-53-36)58(7)47(67)39(22-34-15-10-9-11-16-34)55-45(65)40-18-14-20-59(40)49(69)57-50(27-60,28-61)29-62/h9-13,15-17,19,25,30-33,37-43,60-63H,8,14,18,20-24,26-29H2,1-7H3,(H,51,53)(H,54,66)(H,55,65)(H,56,64)(H,57,69)/t33-,37+,38-,39-,40-,41-,42-,43-/m0/s1
Standard InChI Key: VTDGDPGRUIOAAH-BPVPQGFMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 978.20 | Molecular Weight (Monoisotopic): 977.5586 | AlogP: 1.62 | #Rotatable Bonds: 27 |
Polar Surface Area: 288.74 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 20 | HBD (Lipinski): 9 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.94 | CX Basic pKa: 6.53 | CX LogP: 0.96 | CX LogD: 0.91 |
Aromatic Rings: 3 | Heavy Atoms: 70 | QED Weighted: 0.05 | Np Likeness Score: -0.10 |
1. Bundy GL, Pals DT, Lawson JA, Couch SJ, Lipton MF, Mauragis MA.. (1990) Potent renin inhibitory peptides containing hydrophilic end groups., 33 (8): [PMID:2197413] [10.1021/jm00170a036] |
Source(1):